CareLit · DOI-Nachweis · Klinische Neurophysiologie
Intravenous but not oral application of nimodipine reduces peak systolic flow velocities in vasospastic cerebral arteries following aneurysmatic subarachnoid hemorrhage
DOI 10.1055/s-2006-939326
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Wessig, J Wessig, S Zimmermann, M Rosenkranz, W Niesen
ZeitschriftKlinische Neurophysiologie
Ausgabe03/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Cerebral vasospasm is a major complication of aneurysmal subarachnoid hemorrhage (SAH) and may cause delayed ischemic neurological deficits (DIND). Nimodipine improves the clinical outcome following SAH. A spasmolytic effect of systemic nimodipine administation, however, has not yet been reported. Methods: We prospectively monitored 20 patients with aneurysmal SAH for the occurrence and severity of cereb…
Zitieren
Zitierempfehlung
J Wessig, J Wessig, S Zimmermann, M Rosenkranz, W Niesen (2006) Intravenous but not oral application of nimodipine reduces peak systolic flow velocities in vasospastic cerebral arteries following aneurysmatic subarachnoid hemorrhage. Klinische Neurophysiologie (03). https://doi.org/10.1055/s-2006-939326
Mit CareLit weiterarbeiten